Report cover image

Human Microbiome Market, By Product, By Diseases, By Type, By Route of Administration, By End User, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Publisher AnalystView Market Insights
Published Jun 04, 2025
Length 260 Pages
SKU # ANVM20865186

Description

REPORT HIGHLIGHT

Human microbiome market size was valued at US$ 821.90 Million in 2024, expanding at a CAGR of 31.20% from 2025 to 2032.

The human microbiome refers to the diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body such as the gut, skin, mouth, and respiratory tract. These microorganisms play a vital role in maintaining health by aiding digestion, supporting the immune system, and protecting against pathogens. Disruptions in the microbiome balance are linked to various diseases, including obesity, diabetes, and autoimmune disorders.

Human Microbiome Market- Market Dynamics

Increasing prevalence of chronic diseases to propel market demandThe increasing incidence of chronic conditions such as obesity, diabetes, and inflammatory bowel disease (IBD) is propelling the demand for microbiome-based therapies. According to the World Obesity Atlas 2023, 38% of the global population, approximately 3.12 billion people are overweight or obese. In addition, substantial government funding is accelerating advancements in microbiome science, which is driving the growth of the global human microbiome market. However, high cost of R&D and stringent regulatory frameworks may hamper the market growth during the forecast period. On the contrary, the growing emphasis on personalized healthcare presents opportunities for microbiome-based diagnostics and treatments tailored to individual microbiota profiles.

Human Microbiome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 31.20% over the forecast period (2025-2032)
Based on Product segmentation, probiotics was predicted to show maximum market share in the year 2024
Based on Diseases segmentation, gastrointestinal was the leading Diseases in 2024
Based on Type segmentation, live biotherapeutic products (LBP) was the leading Type in 2024
On the basis of region, North America was the leading revenue generator in 2024

Human Microbiome Market- Segmentation Analysis:

The Global Human Microbiome Market is segmented on the basis of Product, Diseases, Type, Route of Administration, End-user, and Region.
The market is divided into four categories based on Product: prebiotics, probiotics, drugs, and sybnbiotics. The probiotics segment is anticipated to hold the largest market share in the global human microbiome market during the forecast period. This dominance is attributed to increasing consumer awareness of the benefits of probiotics for gut health, immunity, and overall wellness.
The market is divided into four categories based on Diseases: gastrointestinal diseases, infectious diseases, endocrine & metabolic disorders, and other diseases. Among these, the gastrointestinal diseases segment is anticipated to hold the largest market share in the market. This dominance is attributed to the high prevalence of gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD).

Human Microbiome Market- Geographical Insights

The North America region holds the largest share of the global human microbiome market. This dominance is attributed to a well-established healthcare infrastructure, significant investments in microbiome research, and a high prevalence of chronic diseases. Besides, the Asia-Pacific region is projected to experience the fastest growth in the human microbiome market during the forecast period. This rapid expansion is driven by increasing awareness of microbiome health, rising demand for personalized medicine, and advancements in sequencing technologies.

Human Microbiome Market- Competitive Landscape:

Rising interest in personalized medicine and microbiome-based therapies is driving intense competition among companies in this emerging field. Industry participants are focusing on strategic collaborations with research institutions and healthcare providers to accelerate product development. Many are investing heavily in R&D to discover novel microbiome-based diagnostics and therapeutics. Additionally, companies are securing patents and engaging in licensing agreements to strengthen their pipelines. Expansion into untapped regions and the development of consumer-targeted microbiome products also form key competitive strategies.

Recent Developments:

In February 2025, Seres Therapeutics launched SER-109, the first FDA-approved microbiome therapy in the U.S., designed to treat recurrent C. difficile infection by restoring gut microbiota using live bacterial spores.

SCOPE OF THE REPORT


The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN MICROBIOME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

ENTEROME
Pendulum
DuPont
Yakult U.S.A. Inc.
Metabiomics
Vedanta Biosciences, Inc.
Optibiotix Health plc
Microbiome Therapeutics Innovation Group
BioHM Health
Osel, Inc.
Seres Therapeutics
Infinant Health Inc.
Merck & Co., Inc.
Theriva Biologics
Qualigen Therapeutics, Inc.
Synlogic
Symbiotix, LLC
Resbiotic
Symberix, Inc.
Exegi Pharma Inc.
Seed Health Inc.
Biogaia AB
BiomeBank
Ferring Pharmaceuticals
Others

GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Prebiotics
Drugs
Synbiotics

GLOBAL HUMAN MICROBIOME MARKET, BY DISEASES- MARKET ANALYSIS, 2019 - 2032

Gastrointestinal Diseases
Infectious Diseases
Endocrine & Metabolic Disorders
Other Diseases

GLOBAL HUMAN MICROBIOME MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Live Biotherapeutic Products (LBP)
Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
Other Microbiome Types

GLOBAL HUMAN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Rectal
Oral

GLOBAL HUMAN MICROBIOME MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Long-term Care Facilities
Hospitals & Clinics
Others

GLOBAL HUMAN MICROBIOME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Table of Contents

260 Pages
1. Human Microbiome Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Human Microbiome Market Snippet by Product
2.1.2. Human Microbiome Market Snippet by Diseases
2.1.3. Human Microbiome Market Snippet by Type
2.1.4. Human Microbiome Market Snippet by Route of Administration
2.1.5. Human Microbiome Market Snippet by End User
2.1.6. Human Microbiome Market Snippet by Country
2.1.7. Human Microbiome Market Snippet by Region
2.2. Competitive Insights
3. Human Microbiome Key Market Trends
3.1. Human Microbiome Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Human Microbiome Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Human Microbiome Market Opportunities
3.4. Human Microbiome Market Future Trends
4. Human Microbiome Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Human Microbiome Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Human Microbiome Market Landscape
6.1. Human Microbiome Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Human Microbiome Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Probiotics
7.1.3. Drugs
7.1.4. Synbiotics
8. Human Microbiome Market – By Diseases
8.1. Overview
8.1.1. Segment Share Analysis, By Diseases, 2024 & 2032 (%)
8.1.2. Gastrointestinal Diseases
8.1.3. Infectious Diseases
8.1.4. Endocrine & Metabolic Disorders
8.1.5. Other Diseases
9. Human Microbiome Market – By Type
9.1. Overview
9.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
9.1.2. Live Biotherapeutic Products (LBP)
9.1.3. Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
9.1.4. Other Microbiome Types
10. Human Microbiome Market – By Route of Administration
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
10.1.2. Rectal
10.1.3. Oral
11. Human Microbiome Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Long-term Care Facilities
11.1.3. Hospitals & Clinics
11.1.4. Others
12. Human Microbiome Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Human Microbiome Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Human Microbiome Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Human Microbiome Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Human Microbiome Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Human Microbiome Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Human Microbiome Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. ENTEROME
13.2.2. Pendulum
13.2.3. DuPont
13.2.4. Yakult U.S.A. Inc.
13.2.5. Metabiomics
13.2.6. Vedanta Biosciences, Inc.
13.2.7. Optibiotix Health plc
13.2.8. Microbiome Therapeutics Innovation Group
13.2.9. BioHM Health
13.2.10. Osel, Inc.
13.2.11. Seres Therapeutics
13.2.12. Infinant Health Inc.
13.2.13. Merck & Co., Inc.
13.2.14. Theriva Biologics
13.2.15. Qualigen Therapeutics, Inc.
13.2.16. Synlogic
13.2.17. Symbiotix, LLC
13.2.18. Resbiotic
13.2.19. Symberix, Inc.
13.2.20. Exegi Pharma Inc.
13.2.21. Seed Health Inc.
13.2.22. Biogaia AB
13.2.23. BiomeBank
13.2.24. Ferring Pharmaceuticals
13.2.25. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us